BARCLAYS PLC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 39 filers reported holding CUE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$28
-41.7%
12,013
-7.2%
0.00%
Q2 2023$48
+118.2%
12,946
+114.7%
0.00%
Q1 2023$22
+29.4%
6,0290.0%0.00%
Q4 2022$17
-99.9%
6,029
-2.6%
0.00%
Q3 2022$14,000
-22.2%
6,188
-14.2%
0.00%
Q2 2022$18,000
-70.0%
7,214
-40.9%
0.00%
Q1 2022$60,000
-94.0%
12,211
-86.3%
0.00%
Q4 2021$1,006,000
+249.3%
88,842
+349.0%
0.00%
Q3 2021$288,000
+336.4%
19,785
+251.3%
0.00%
Q2 2021$66,000
-78.1%
5,632
-77.2%
0.00%
Q1 2021$302,000
+81.9%
24,730
+85.4%
0.00%
Q4 2020$166,000
-42.0%
13,342
-29.9%
0.00%
Q3 2020$286,000
-24.9%
19,028
+22.4%
0.00%
Q2 2020$381,000
+305.3%
15,547
+133.0%
0.00%
Q1 2020$94,000
-70.3%
6,672
-66.6%
0.00%
Q4 2019$317,000
+164.2%
19,957
+40.2%
0.00%
Q3 2019$120,000
+14.3%
14,235
+22.4%
0.00%
Q2 2019$105,000
+162.5%
11,632
+126.5%
0.00%
Q1 2019$40,000
-33.3%
5,136
-22.5%
0.00%
Q3 2018$60,000
+300.0%
6,628
+412.2%
0.00%
Q2 2018$15,000
-42.3%
1,294
-29.8%
0.00%
Q1 2018$26,0001,8430.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Prosight Management, LP 1,510,282$7,370,0004.76%
SANDERS MORRIS HARRIS LLC 873,021$4,261,0000.83%
P.A.W. CAPITAL CORP 150,000$732,0000.76%
Nantahala Capital Management 2,244,359$10,952,0000.48%
Bleichroeder LP 552,000$2,694,0000.48%
APOGEM CAPITAL LLC 111,259$543,0000.37%
Slate Path Capital LP 1,483,619$7,240,0000.37%
Robertson Stephens Wealth Management, LLC 478,500$2,335,0000.20%
CARLSON CAPITAL L P 405,000$1,976,0000.14%
Bridgefront Capital, LLC 19,968$97,0000.12%
View complete list of CUE BIOPHARMA INC shareholders